Phase II Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme

Trial Profile

Phase II Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2015

At a glance

  • Drugs Lenalidomide (Primary) ; Irinotecan
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top